Approval · Notice of Compliance 14105 · 2013
VISUDYNE: Notice of Compliance 14105
Issued February 14, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14105
- Date
- February 14, 2013
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Photosensitizing agent for photodynamic therapy of choroidal neovascularization
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VISUDYNE | 02242367 | Marketed |
Medicinal ingredients
- VERTEPORFIN 15 MG per VIAL